Physician profile
Katherine Garrity
NPI 1891038907
$497.66
in general payments reported to CMS, 2019-2025
17 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $142 · 2024: $208 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $52.68 | 2023-2024 | Dupixent |
| Leo Pharma INC. | $50.86 | 2024-2025 | Adbry |
| Incyte Corporation | $48.60 | 2023-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $43.64 | 2023-2025 | Sotyktu |
| Ucb, INC. | $36.98 | 2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $33.48 | 2025 | Zoryve |
| Kyowa Kirin, INC. | $31.28 | 2025 | |
| Sun Pharmaceutical Industries INC. | $30.96 | 2023 | Winlevi, Ilumya |
| Galderma Laboratories, L.P. | $29.85 | 2023-2025 | Nemluvio, Aklief |
| Janssen Biotech, INC. | $29.08 | 2024 | Tremfya, Stelara, Simponi Aria |
| Verrica Pharmaceuticals INC. | $18.86 | 2024 | Ycanth |
| Dermavant Sciences, INC. | $17.85 | 2023 | Vtama |
| Abbvie INC. | $16.33 | 2024 | |
| Amgen INC. | $15.79 | 2024 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.62 | 2023 | Spevigo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13.54 | 2024 | Collagenase Santyl |
| Genzyme Corporation | $13.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Garrity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.